2017
DOI: 10.4103/ijc.ijc_452_17
|View full text |Cite
|
Sign up to set email alerts
|

Neoadjuvant chemoradiation for locally advanced resectable carcinoma of the esophagus: A single-center experience from India with a brief review of the literature

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 31 publications
0
8
0
Order By: Relevance
“…The range varies from 18.5 Gy to 50.4 Gy with different fractionation schedules. [3][4][5][6][7][8][9][10] We implemented conventional fractionation schedules at doses of 41.4 Gy to 45 Gy with either 3DCRT or IMRT planning. The concomitant chemotherapy administered along with radiotherapy in neoadjuvant setting varies in different studies.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The range varies from 18.5 Gy to 50.4 Gy with different fractionation schedules. [3][4][5][6][7][8][9][10] We implemented conventional fractionation schedules at doses of 41.4 Gy to 45 Gy with either 3DCRT or IMRT planning. The concomitant chemotherapy administered along with radiotherapy in neoadjuvant setting varies in different studies.…”
Section: Discussionmentioning
confidence: 99%
“…The pathological complete response rate was 40%, which is comparable with the published literature. [3][4][5][6][7][8][9][10] The OS of patients who underwent the trimodality treatment and those who defaulted for surgery after neoadjuvant treatment was 18.5 months and 8 months, respectively, showing the obvious benefit of the completion surgery (►Fig. 1).…”
Section: Discussionmentioning
confidence: 99%
“…The mean BMI in our patient cohort was 19.72 (range: 12-49). The mean BMI among the male patients was 19.81 , whereas it was 19.57 (13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30)(31) among the female patients (p = 0.61).…”
Section: Body Mass Indexmentioning
confidence: 94%
“…Following the publication of the results of CROSS trial, 31 our preferred choice of the management of locally advanced ECs has shifted to neoadjuvant chemoradiation followed by surgery. 30 There are very sparse published Indian data pertaining to the demographic trends of ECs, the most of which are case-control studies. 12,32,33 The main limitation of this study was that it was based on retrospective data gathered from a single tertiary care center.…”
Section: Comparative Demographic Trendsmentioning
confidence: 99%
“…The mean Body Mass Index (BMI) in our patient cohort was 19.72 (range: 12-49). The mean BMI among the male patients was 19.81 , while it was 19.57 (13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30)(31) among the female patients (p = 0.61).…”
Section: Body Mass Indexmentioning
confidence: 96%